Resolving Conflicts in Non-face-to-face Medical treatment

Improve the pilot project plan as soon as possible, such as narrow scope and ambiguity of re-up standards

Responding to the written question of Rep. Choi Young-hee of the National Assembly Welfare Committee

The Ministry of Health and Welfare cited the legalization of non-face-to-face treatment through the revision of the Medical Act as a solution to resolve the conflict between the medical community and the medical community surrounding non-face-to-face-face treatment.

 

In addition, the MOHW expressed his will to improve the non-face-to-face treatment pilot project as soon as possible, reflecting the on-site opinion that the scope of the first diagnosis is narrow, the criteria for re-examination is vague, and there is a gap between the medical field.

 

On the 26th, the Ministry of Health and Welfare responded to the written question of Rep.

 

Choi Young-hee, a member of the National Assembly Health and Welfare Committee.

 

Rep.

 

Choi Young-hee pointed out that it is necessary to institutionalize non-face-to-face treatment through the revision of the Medical Act based on the temporary non-face-to-face treatment results, but it is in a shutdown situation due to the non-infection of legalization.

 

In response, the Ministry of Health and Welfare explained that the temporary non-face-to-face treatment conducted from the 2nd of 2020 to May of this year is only 0.3% of the total number of outpatient visits, and the pilot project carried out in June and July this year accounts for 0.2%, and explained that non-face-to-face-to-face treatment is being used as an auxiliary means of face-to-face treatment.

 

The Ministry of Health and Welfare responded that revision of the law is essential to provide stable and predictable non-face-to-face treatment to the public, and it is urgent to deliberate on the revision of the medical law.

 

In particular, the Ministry of Health and Welfare is that in order to resolve conflicts with the medical community and the pharmaceutical community, the National Assembly needs to reach a social agreement by revising the medical law.

 

Furthermore, the Ministry of Health and Welfare has revealed a plan to objectively analyze and improve the current non-face-to-face treatment pilot project.

 

The plan is to revise and improve the scope of the pilot project as soon as possible, reflecting the opinion that the scope of the initial diagnosis is too narrow and the criteria for re-examination is ambiguous, so there is a gap with the medical field.

 

The Ministry of Health and Welfare said, "We will continue to prepare legislative and policy improvement measures for non-face-to-face treatment by reflecting the opinions of the field, evaluation and analysis results of pilot projects, discussions of advisory group, and satisfaction survey results.

 

Legalization is essential to prevent illegal acts related to non-face-face-to-face treatment in advance and provide non-to-face treatment stably."